NTRR Targets $52 Billion Pain Management Market
NTRR Targets $52 Billion Pain Management Market
SARASOTA, Fla.--(BUSINESS WIRE)-- Cutting-edge lifestyle company Neutra Corp. (OTCBB: NTRR), through a key new partnership with an innovative cannabis delivery systems provider in the medical marijuana industry, is poised to make an impact in the lucrative $52 billion pain management market.
With partner Field of View Technologies, LLC, exploring new technology in cannabis delivery systems, NTRR is ready to provide much-needed smokeless delivery systems to those most in need: patients forced to live with debilitating pain.
A recent study by Columbia University found that smoke-free cannabinoid medication was effective in treating pain. Smokeless delivery systems can be administered orally, by injection or topically, giving the patient the choice of treatment method as NTRR and Field of View set the pace in the potentially lucrative pain management market.
"Field of View Technology's creative, high-tech delivery systems will be the answer for many sufferers of chronic pain," NTRR CEO Sydney Jim said. "Smoke-free cannabis deliveries are the wave of the future, and with Field of View we're going to be pioneers in this field."
Through Cannabis Technologies, Inc., NTRR is working to help introduce the next wave of healthier, more efficient systems to the ever-growing $1.7 billion MMJ market. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR's initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS:
The article NTRR Targets $52 Billion Pain Management Market originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
